These final results, along with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 support the idea of concentrating on ACKR3 as a novel method to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated disorders. We independently analysis, https://popex898ixh6.wikissl.com/user